TrademarkOpen
Search / United States / 98195945

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

REMSEQ

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders…
Show more

Class 5: Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system relat…
Class 42: development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 16 May 2024
    Assigned to an examining attorney
    Assigned To Examiner
  2. 17 May 2024
    Office action issued
    Non-Final Action Written
  3. 26 Jun 2024
    Response to office action filed
    Teas Response To Office Action Received
  4. 27 Jun 2024
    Office action issued
    Non-Final Action Written
  5. 23 Sep 2024
    Response to office action filed
    Teas Response To Office Action Received
  6. 3 Oct 2024
    Final refusal issued
    Final Refusal Mailed
  7. 21 Oct 2024
    Approved for publication
    Approved For Pub - Principal Register
  8. 24 Dec 2024
    Published for opposition
    Published For Opposition
  9. 18 Feb 2025
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  10. 18 Aug 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  11. 18 Feb 2026
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  12. 17 Aug 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 41 events
2026-08-18Notice Of Approval Of Extension Request E-Mailed
2026-08-17Sou Teas Extension Received
2026-08-17Sou Extension 3 Filed
2026-08-17Sou Extension 3 Granted
2026-02-19Notice Of Approval Of Extension Request E-Mailed
2026-02-18Sou Teas Extension Received
2026-02-18Sou Extension 2 Filed
2026-02-18Sou Extension 2 Granted
2025-08-19Notice Of Approval Of Extension Request E-Mailed
2025-08-18Sou Teas Extension Received
2025-08-18Sou Extension 1 Filed
2025-08-18Sou Extension 1 Granted
2025-04-23Teas Change Of Owner Address Received
2025-04-23Applicant/Correspondence Changes (Non-Responsive) Entered
2025-04-23Teas Change Of Correspondence Received
2025-02-18Noa Mailed - Sou Required From Applicant
2024-12-24Published For Opposition
2024-12-24Official Gazette Publication Confirmation E-Mailed
2024-12-18Notification Of Notice Of Publication E-Mailed
2024-10-21Examiners Amendment -Written
2024-10-21Examiners Amendment E-Mailed
2024-10-21Notification Of Examiners Amendment E-Mailed
2024-10-21Examiner's Amendment Entered
2024-10-21Approved For Pub - Principal Register
2024-10-03Final Refusal Mailed
2024-10-03Final Refusal E-Mailed
2024-10-03Notification Of Final Refusal Emailed
2024-09-23Teas Response To Office Action Received
2024-09-23Correspondence Received In Law Office
2024-09-23Teas/Email Correspondence Entered
2024-06-27Non-Final Action Written
2024-06-27Non-Final Action E-Mailed
2024-06-27Notification Of Non-Final Action E-Mailed
2024-06-26Teas Response To Office Action Received
2024-06-26Correspondence Received In Law Office
2024-06-26Teas/Email Correspondence Entered
2024-05-17Non-Final Action Written
2024-05-17Non-Final Action E-Mailed
2024-05-17Notification Of Non-Final Action E-Mailed
2024-05-16Assigned To Examiner
2023-10-10New Application Office Supplied Data Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system relat…

Class 42 Technology & SaaS

development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 18 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.